Metabolic research
Retatrutide (20mg)
Retatrutide is a multi-receptor incretin research compound studied across GLP-1, GIP, and glucagon receptor signaling in metabolic-pathway models.
99.518% purity. Lab result linked.
Price
$150.00
20mg lyophilized vial
JAN-151624
Testing detailsOpenClose
Batch
JAN-151624
Purity
99.518%
Assayed mass
22.16mg
Lab result
Janoshik
Test date
2026-05-19
Lab result linked
Third-party result available.
This matched Janoshik link is kept here as a supporting product detail.
Product
Retatrutide (20mg)
Batch
JAN-151624
Status
Available
Record: Janoshik direct lab resultOpen lab result
Product notesOpenClose
- Description
- Retatrutide is a multi-receptor incretin research compound studied across GLP-1, GIP, and glucagon receptor signaling in metabolic-pathway models.
- Concentration
- 20mg
- Storage
- Store sealed and temperature controlled. Keep protected from light.
- Format
- Synthetic peptide, lyophilized research format
- Reference
- Royalis Janoshik lab result linked to this product.
ShippingOpenClose
Ships within Canada via Canada Post.
Discreet packaging is listed in the Royalis FAQ.
Tracking is provided for all orders.